Assetmark »

Ascendis Pharma AS shares owned by Assetmark

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Assetmark

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.6M 14k 266.72

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Ishares Core Msci Emkt (IEMG)
Microsoft Corporation (MSFT)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Series Trust St Bloo High Etf (JNK)

View all positions for Assetmark

Top funds holding Ascendis Pharma AS

T. Rowe Price Associates
Pictet Asset Management Holding SA
A.R. Schmeidler & Co
New York State Common Retirement Fund
Driehaus Capital Management
Q Global Advisors
Sapient Capital
Tudor Investment Corporation
Standard Life Aberdeen
Handelsbanken Fonder AB
Diversified Trust Company
Henry James International Management
Sterling Capital Management
Assetmark
Mediolanum International Funds

View all funds holding Ascendis Pharma AS